1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. Market Drivers
4.1 Chronic and Infectious Diseases
4.2 New Technologies
4.3 Emerging Markets
4.4 Diversifying Applications
4.5 Healthcare Infrastructure
5. Clinical Segmentation Outlook 2013
5.1 Point-of-Care Diagnostics
5.2 Clinical Chemistry and Immunochemistry
5.3 Molecular Diagnostics
5.4 Microbiology
5.5 Hemostasis
5.6 Hematology
5.7 Immunohematology
6. Segmentation by Indication (Current & Future Scenario - 2013)
6.1 Diabetes
6.2 Cardiovascular
6.3 Cancer
6.4 HIV
6.5 Tuberculosis
6.6 Influenza
7. Geographical Segmentation (Current & Future Scenario - 2013)
7.1 North America
7.1.1 United States
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 United Kingdom
7.2.5 Spain
7.2.6 Other European Countries
7.3 Japan
7.4 Other Key Countries
7.4.1 China
7.4.2 India
7.4.3 Turkey
7.4.4 Brazil
7.4.5 Mexico
8. Consumer Behavior Analysis
9. Emerging Sectors
9.1 Companion Diagnostics/Theranostics
9.2 Nanodiagnostics
10. Recent Developments and M&As
11. Industry Restraints
11.1 Regulatory and Reimbursement Issues
11.2 R&D and Short Product Lifecycle
11.3 Cost Control
12. Competitive Landscape
12.1 Market Share of Top Players
12.2 Key Players
12.2.1 Roche Holding Ltd.
12.2.2 Abbott Laboratories
12.2.3 Siemens AG
12.2.4 Beckman Coulter
12.2.5 Ortho-Clinical Diagnostics
